Metaphase cytogenetics and DNA flow cytometry with analysis of S-phase fraction in prostate cancer: influence on prognosis (Q38478864)

3 September 2017

Metaphase cytogenetics and DNA flow cytometry with analysis of S-phase fraction in prostate cancer: influence on prognosis (English)

1 reference

3 September 2017

1 reference

1 reference

Bratt O

1

1 reference

3 September 2017

Anderson H

2

1 reference

3 September 2017

Bak-Jensen E

3

1 reference

3 September 2017

Baldetorp B

4

1 reference

3 September 2017

Lundgren R

5

1 reference

3 September 2017

language of work or name

English

0 references

publication date

1 February 1996

1 reference

3 September 2017

1 reference

3 September 2017

47

1 reference

3 September 2017

2

1 reference

3 September 2017

218-224

1 reference

Chromosome abnormalities are associated with unfavorable outcome in prostatic cancer patients

3 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980420-8

7 January 2021

Prognostic value of deoxyribonucleic acid content in prostate cancer: a review of current results

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980420-8

7 January 2021

Flow cytometric measurements of DNA and other cell components in human tumors: a critical appraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980420-8

7 January 2021

Indicators of prognosis in node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980420-8

7 January 2021

Prognostic value of DNA ploidy and S-phase fraction in endometrial cancer stage I and II: a prospective 5-year survival study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980420-8

7 January 2021

Cytogenetic analysis of 57 primary prostatic adenocarcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980420-8

7 January 2021

Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980420-8

7 January 2021

Flow cytometric determination of DNA ploidy level in nuclei isolated from paraffin-embedded tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980420-8

7 January 2021

Statistical evaluation of cell kinetic data from DNA flow cytometry (FCM) by the EM algorithm

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980420-8

7 January 2021

Analysis of PCP-data to determine the fraction of cells in the various phases of cell cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980420-8

7 January 2021

DNA heterogeneity in prostatic adenocarcinoma. A DNA flow cytometric mapping study with whole organ sections of prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980420-8

7 January 2021

Tissue culture loss of aneuploid cells from carcinomas of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980420-8

7 January 2021

Flow cytometry using paraffin-embedded tissue: five years on.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980420-8

7 January 2021

Use of fluorescent in situ hybridization for deoxyribonucleic acid ploidy analysis of prostatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980420-8

7 January 2021

Flow cytometric analysis of DNA ploidy and S-phase fraction from prostatic carcinomas: implications for prognosis and response to endocrine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980420-8

7 January 2021

Flow cytometric analysis of DNA ploidy, percent S-phase fraction, and total proliferative fraction as prognostic indicators of local control and survival following radiation therapy for prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980420-8

7 January 2021

Progression and survival in prostatic adenocarcinoma: a comparison of clinical stage, Gleason grade, S-phase fraction and DNA ploidy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980420-8

7 January 2021

Proliferative activity determined by DNA flow cytometry and proliferating cell nuclear antigen (PCNA) immunohistochemistry as a prognostic factor in prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980420-8

7 January 2021

Quality control for evaluation of the S-phase fraction by flow cytometry: a multicentric study. The SICCAB Group for Quality Control of Cell Kinetic Determinations

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980420-8

7 January 2021

10.1016/S0090-4295(99)80420-8

Identifiers

DOI

1 reference

3 September 2017

1 reference